{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:01:15Z","timestamp":1790254875811,"version":"4.1.0"},"reference-count":104,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1097\/sla.0b013e3181f3efb0","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T04:17:16Z","timestamp":1284697036000},"page":"915-928","source":"Crossref","is-referenced-by-count":111,"title":["Clinical Operational Tolerance After Renal Transplantation"],"prefix":"10.1097","volume":"252","author":[{"given":"Giuseppe","family":"Orlando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiman","family":"Hematti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Stratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo Di","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay","family":"Soker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210203","first-page":"110","article-title":"Can immune monitoring help to minimize immunosuppression in kidney transplantation Transplant Int.","volume":"22","author":"Ashton-Chess","year":"2009","journal-title":""},{"key":"R2-5-20210203","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/01.TP.0000092955.28529.1E","article-title":"Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantation.","volume":"76","author":"Karam","year":"2003","journal-title":"Transplantation"},{"key":"R3-5-20210203","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/S0140-6736(07)60762-4","article-title":"Clinical update: immunosuppression minimisation.","volume":"369","author":"Sayegh","year":"2007","journal-title":"Lancet"},{"key":"R4-5-20210203","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.tp.0000290683.54937.1b","article-title":"Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation.","volume":"84","author":"Ashton-Chess","year":"2007","journal-title":"Transplantation"},{"key":"R5-5-20210203","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2009.03.006","article-title":"Clinical operational tolerance after liver transplantation.","volume":"50","author":"Orlando","year":"2009","journal-title":"J Hepatol"},{"key":"R6-5-20210203","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1432-2277.2008.00758.x","article-title":"Minimization of steroids in liver transplantation.","volume":"22","author":"Lerut","year":"2009","journal-title":"Transplant Int"},{"key":"R7-5-20210203","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1432-2277.2008.00765.x","article-title":"Monitoring of human liver and kidney allograft tolerance: a tissuehistopathology perspective.","volume":"22","author":"Demetris","year":"2009","journal-title":"Transplant Int"},{"key":"R8-5-20210203","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/TP.0b013e318188d3e6","article-title":"FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.","volume":"86","author":"Pons","year":"2008","journal-title":"Transplantation"},{"key":"R9-5-20210203","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1183\/09031936.95.08020334","article-title":"Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow.","volume":"8","author":"Svendsen","year":"1995","journal-title":"Eur Respir J"},{"key":"R10-5-20210203","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.healun.2009.04.011","article-title":"Immune tolerance after total lymphoid irradiation for heart transplantation: immunosuppressant-free survival for 8 years.","volume":"28","author":"Comerci","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R11-5-20210203","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/jama.1956.02960390027008","article-title":"Successful homotransplantation of the human kidney between identical twins.","volume":"160","author":"Merrill","year":"1956","journal-title":"JAMA"},{"key":"R12-5-20210203","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trim.2004.05.009","article-title":"Tolerance induction in clinical transplantation.","volume":"13","author":"Fehr","year":"2004","journal-title":"Transplant Immunol"},{"key":"R13-5-20210203","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00000658-198007000-00018","article-title":"Renal isotransplantation without immunosuppression.","volume":"192","author":"Weil","year":"1980","journal-title":"Ann Surg"},{"key":"R14-5-20210203","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.1981.03310260046030","article-title":"Kidney transplantation in monozygotic twins discordant for Lupus.","volume":"245","author":"Zonnebelt","year":"1981","journal-title":"JAMA"},{"key":"R15-5-20210203","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00007890-199504270-00013","article-title":"Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness clonal anergy in a tolerant renal transplant recipient.","volume":"59","author":"Burlingham","year":"1995","journal-title":"Transplantation"},{"key":"R16-5-20210203","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1016\/j.transproceed.2006.08.173","article-title":"Embryonic stem cell derived and adult hematopoietic stem cell transplantation for tolerance induction in a renal allograft recipient: a case report.","volume":"38","author":"Trivedi","year":"2006","journal-title":"Transplant Proc"},{"key":"R17-5-20210203","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/00007890-199604150-00023","article-title":"Association of interleukin-10 with rejection-sparing effect in septic kidney transplant recipients.","volume":"61","author":"Burke","year":"1996","journal-title":"Transplantation"},{"key":"R18-5-20210203","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/archsurg.1975.01360180020004","article-title":"Discontinuance of immunosuppression in renal transplant patients.","volume":"110","author":"Owens","year":"1975","journal-title":"Arch Surg"},{"key":"R19-5-20210203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ki.1980.116","article-title":"Cessation of immunosuppressive therapy after successful transplantation: a national survey.","volume":"18","author":"Zoller","year":"1980","journal-title":"Kidney Int"},{"key":"R20-5-20210203","first-page":"1451","article-title":"Editorial comment.","volume":"110","author":"Najarian","year":"1975","journal-title":"Arch Surg"},{"key":"R21-5-20210203","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archsurg.1976.01360230114029","article-title":"Letter: Discontinuance of immunosuppression.","volume":"111","author":"Hussey","year":"1975","journal-title":"Arch Surg"},{"key":"R22-5-20210203","first-page":"278","article-title":"Cessation of immunosuppression after renal transplantation.","volume":"79","author":"Uehling","year":"1976","journal-title":"Surgery"},{"key":"R23-5-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI9171","article-title":"Human allograft acceptance is associated with immune regulation.","volume":"106","author":"Van Buskirk","year":"2000","journal-title":"J Clin Invest"},{"key":"R24-5-20210203","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.4049\/jimmunol.178.6.3983","article-title":"Human CD4 CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance.","volume":"178","author":"Xu","year":"2007","journal-title":"J Immunol"},{"key":"R25-5-20210203","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0301-2115(95)02581-2","article-title":"Specific immune tolerance during pregnancy after renal transplantation.","volume":"70","author":"Fischer","year":"1996","journal-title":"Eur J Obst Gyn"},{"key":"R26-5-20210203","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ni1317","article-title":"Mothers little helpers: mechanisms of maternal-fetal tolerance.","volume":"7","author":"Trowsdale","year":"2005","journal-title":"Nat Immunol"},{"key":"R27-5-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MOT.0b013e32832d6683","article-title":"Tolerance to noninherited maternal antigens in mice and humans.","volume":"14","author":"Dutta","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"R28-5-20210203","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/01.TP.0000117781.50131.55","article-title":"Toward tolerance to human organ transplants: a few additional corollaries and questions.","volume":"77","author":"Miller","year":"2004","journal-title":"Transplantation"},{"key":"R29-5-20210203","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1600-6143.2006.01280.x","article-title":"Clinical operational tolerance after kidney transplantation.","volume":"6","author":"Roussey-Kesler","year":"2006","journal-title":"Am J Transplant"},{"key":"R30-5-20210203","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/j.1600-6143.2006.01533.x","article-title":"Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft.","volume":"6","author":"Ballet","year":"2006","journal-title":"Am J Transplant"},{"key":"R31-5-20210203","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000203166.44968.86","article-title":"Contrasting CD25hiCD4 T cellsFOXP3 patterns in chronic rejection and operational drug-free tolerance.","volume":"81","author":"Louis","year":"2006","journal-title":"Transplantation"},{"key":"R32-5-20210203","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1681\/ASN.2005020178","article-title":"Phenotypically and functionally distinct CD8 lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients.","volume":"17","author":"Baeten","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R33-5-20210203","first-page":"330","article-title":"Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation.","volume":"5","author":"Brouard","year":"2005","journal-title":"Is J Transplant"},{"key":"R34-5-20210203","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/TP.0b013e31817b8dc5","article-title":"Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.","volume":"86","author":"Braudeau","year":"2008","journal-title":"Transplantation"},{"key":"R35-5-20210203","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1073\/pnas.0705834104","article-title":"Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance.","volume":"104","author":"Brouard","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R36-5-20210203","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jcb.21574","article-title":"Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis.","volume":"103","author":"Braud","year":"2008","journal-title":"J Cell Biochem"},{"key":"R37-5-20210203","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/jcb.21557","article-title":"Immunosuppressive drug-free operational immune tolerance in human kidney transplants recipients. Part II. Non-statistical gene microarray analysis.","volume":"103","author":"Sivozhelezov","year":"2008","journal-title":"J Cell Biochem"},{"key":"R38-5-20210203","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1399-0039.1998.tb03006.x","article-title":"Indications of immunological tolerance in kidney transplantation.","volume":"51","author":"Christensen","year":"1998","journal-title":"Tissue Antigens"},{"key":"R39-5-20210203","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","article-title":"Tolerogenic immunosuppression for organ transplantation.","volume":"361","author":"Starzl","year":"2003","journal-title":"Lancet"},{"key":"R40-5-20210203","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-6143.2007.02078.x","article-title":"Homeostatic repopulation by CD28-CD8 T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression.","volume":"8","author":"Trzonkowski","year":"2008","journal-title":"Am J Transplant"},{"key":"R41-5-20210203","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/TP.0b013e31819d3353","article-title":"Alemtuzumab CAMPATH-1H for the treatment of acute rejection in kidney transplant recipients: long-term follow-up.","volume":"87","author":"Clatworthy","year":"2009","journal-title":"Transplantation"},{"key":"R42-5-20210203","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1600-6143.2005.00822.x","article-title":"Alemtuzumab CAMPATH 1H induction therapy in cadaveric kidney transplantationefficacy and safety at five years.","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"},{"key":"R43-5-20210203","first-page":"301","article-title":"Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients.","volume":"101","author":"Calne","year":"2000","journal-title":"Nippon Geka Gakkai Zasshi"},{"key":"R44-5-20210203","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/00007890-199911270-00032","article-title":"Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.","volume":"68","author":"Calne","year":"1999","journal-title":"Transplantation"},{"key":"R45-5-20210203","first-page":"408","article-title":"Prope tolerance, perioperative Campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet. 1998; 351:1701-1702.","volume":"352","author":"Calne","year":"1998","journal-title":"Erratum in: Lancet"},{"key":"R46-5-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trim.2008.09.003","article-title":"The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation.","volume":"20","author":"Agarwal","year":"2008","journal-title":"Transplant Immunol"},{"key":"R47-5-20210203","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.TP.0000071362.99021.D9","article-title":"Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab CAMPATH-1H.","volume":"76","author":"Kirk","year":"2003","journal-title":"Transplantation"},{"key":"R48-5-20210203","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.tp.0000174341.49741.8f","article-title":"Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin.","volume":"80","author":"Kirk","year":"2005","journal-title":"Transplantation"},{"key":"R49-5-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-6143.2007.02053.x","article-title":"Alemtuzumab Campath-1H in kidney transplantation.","volume":"8","author":"Ciancio","year":"2008","journal-title":"Am J Transplant"},{"key":"R50-5-20210203","first-page":"338","article-title":"Homeostatic Am J Transplant.","volume":"8","author":"Trzonkowski","year":"2008","journal-title":""},{"key":"R51-5-20210203","first-page":"1157","article-title":"Tolerance: is it worth the risk Transplantation.","volume":"79","author":"Eason","year":"2005","journal-title":""},{"key":"R52-5-20210203","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1600-6143.2005.00759.x","article-title":"Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.","volume":"5","author":"Pearl","year":"2005","journal-title":"Am J Transplant"},{"key":"R53-5-20210203","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/01.tp.0000239268.64408.84","article-title":"Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.","volume":"82","author":"Trzonkowski","year":"2006","journal-title":"Transplantation"},{"key":"R54-5-20210203","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trim.2004.05.006","article-title":"Donor bone marrow transplantation, chimerism and tolerance.","volume":"13","author":"Delis","year":"2004","journal-title":"Transplant Immunol"},{"key":"R55-5-20210203","doi-asserted-by":"crossref","first-page":"954","DOI":"10.7326\/0003-4819-114-11-954","article-title":"Immunologic tolerance to renal allografts after bone marrow transplants from the same donors.","volume":"114","author":"Sayegh","year":"1991","journal-title":"Ann Int Med"},{"key":"R56-5-20210203","first-page":"1420","article-title":"Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation.","volume":"58","author":"Helg","year":"1994","journal-title":"Transplantation"},{"key":"R57-5-20210203","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0140-6736(94)91881-3","article-title":"Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor.","volume":"343","author":"Jacobsen","year":"1994","journal-title":"Lancet"},{"key":"R58-5-20210203","first-page":"1633","article-title":"Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation.","volume":"59","author":"Sorof","year":"1995","journal-title":"Transplantation"},{"key":"R59-5-20210203","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1399-0012.1999.130409.x","article-title":"Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression.","volume":"13","author":"Butcher","year":"1999","journal-title":"Clin Transplant"},{"key":"R60-5-20210203","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/00007890-200106150-00031","article-title":"Tolerance in renal transplantation after allogeneic bone marrow transplantation6-year follow-up.","volume":"71","author":"Sellers","year":"2001","journal-title":"Transplantation"},{"key":"R61-5-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1034\/j.1399-0012.2002.02056.x","article-title":"Bone marrow transfusions in cadaver renal allografts: pilot trials with concurrent controls.","volume":"16","author":"Light","year":"2002","journal-title":"Clin Transplant"},{"key":"R62-5-20210203","first-page":"633","article-title":"Should we be performing more combined hematopoietic stem cell plus solid organ transplants Bone Marrow Transplant.","volume":"31","author":"Chiang","year":"2003","journal-title":""},{"key":"R63-5-20210203","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/172603a0","article-title":"Activity acquired tolerance of foreign cells.","volume":"172","author":"Billingham","year":"1953","journal-title":"Nature"},{"key":"R64-5-20210203","first-page":"384","article-title":"Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum ALS and donor bone marrow: case report of an initial attempt.","volume":"79","author":"Monaco","year":"1976","journal-title":"Surgery"},{"key":"R65-5-20210203","first-page":"489","article-title":"Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.","volume":"2","author":"Monaco","year":"1970","journal-title":"Transplant Proc"},{"key":"R66-5-20210203","first-page":"1312","article-title":"Attempt to induce unresponsiveness to human renal allografts with antilymphocyte globulin and donor-specific bone marrow.","volume":"27","author":"Monaco","year":"1985","journal-title":"Transplant Proc"},{"key":"R67-5-20210203","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/TP.0b013e31819535c2","article-title":"Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials.","volume":"87","author":"Sykes","year":"2009","journal-title":"Transplantation"},{"key":"R68-5-20210203","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00007890-199101000-00011","article-title":"Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.","volume":"51","author":"Barber","year":"1991","journal-title":"Transplantation"},{"key":"R69-5-20210203","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0966-3274(03)00056-X","article-title":"Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.","volume":"11","author":"Mathew","year":"2003","journal-title":"Transplant Immunol"},{"key":"R70-5-20210203","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3349\/ymj.2004.45.6.998","article-title":"Donor bone marrow infusion in deceased and living donor renal transplantation.","volume":"45","author":"Ciancio","year":"2004","journal-title":"Yonsei Med J"},{"key":"R71-5-20210203","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1093\/ndt\/gfh274","article-title":"A strategy to achieve donor-specific hyporesponsiveness in cadaver renal allograft recipients by donor haematopoietic stem cell transplantation into the thymus and periphery.","volume":"19","author":"Trivedi","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R72-5-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1399-3046.2002.1o043.x","article-title":"High-dose peripheral blood stem cell infusion: a strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients.","volume":"6","author":"Trivedi","year":"2002","journal-title":"Pediatr Transplant"},{"key":"R73-5-20210203","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1600-6143.2006.01434.x","article-title":"Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.","volume":"6","author":"Fudaba","year":"2006","journal-title":"Am J Transplant"},{"key":"R74-5-20210203","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00007890-200211270-00011","article-title":"Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.","volume":"74","author":"Buhler","year":"2002","journal-title":"Transplantation"},{"key":"R75-5-20210203","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199908270-00006","article-title":"Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism.","volume":"68","author":"Spitzer","year":"1999","journal-title":"Transplantation"},{"key":"R76-5-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"358","author":"Kawai","year":"2008","journal-title":"N Engl J Med"},{"key":"R77-5-20210203","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0198-8859(00)00217-2","article-title":"Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.","volume":"61","author":"Burlingham","year":"2000","journal-title":"Hum Immunol"},{"key":"R78-5-20210203","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/00007890-200205150-00005","article-title":"Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.","volume":"73","author":"Millan","year":"2002","journal-title":"Transplantation"},{"key":"R79-5-20210203","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa074191","article-title":"Tolerance and chimerism after renal and hematopoietic-cell transplantation.","volume":"358","author":"Scandling","year":"2008","journal-title":"N Engl J Med"},{"key":"R80-5-20210203","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1432-2277.2008.00692.x","article-title":"A cell-based approach to the minimization of immunosuppression in renal transplantation.","volume":"21","author":"Hutchinson","year":"2008","journal-title":"Transplant Int"},{"key":"R81-5-20210203","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1432-2277.2008.00680.x","article-title":"Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation.","volume":"21","author":"Hutchinson","year":"2008","journal-title":"Transplant Int"},{"key":"R82-5-20210203","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.trre.2008.05.002","article-title":"Role of mesenchymal stromal cells in solid organ transplantation.","volume":"22","author":"Hematti","year":"2008","journal-title":"Transplant Rev"},{"key":"R83-5-20210203","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"R84-5-20210203","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2796.2007.01844.x","article-title":"Immunomodulation by mesenchymal stem cells and clinical experience.","volume":"262","author":"Le Blanc","year":"2007","journal-title":"J Intern Med"},{"key":"R85-5-20210203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1432-2277.2008.00786.x","article-title":"Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation.","volume":"22","author":"Crop","year":"2009","journal-title":"Transplant Int"},{"key":"R86-5-20210203","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2337\/db09-0317","article-title":"Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and 9.","volume":"58","author":"Ding","year":"2009","journal-title":"Diabetes"},{"key":"R87-5-20210203","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/TP.0b013e3181b4425a","article-title":"MISOT Study Group. Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study group.","volume":"88","author":"Dahlke","year":"2009","journal-title":"Transplantation"},{"key":"R88-5-20210203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM198907063210106","article-title":"Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation.","volume":"321","author":"Strober","year":"1989","journal-title":"N Engl J Med"},{"key":"R89-5-20210203","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1097\/00007890-200004270-00005","article-title":"Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity.","volume":"69","author":"Strober","year":"2000","journal-title":"Transplantation"},{"key":"R90-5-20210203","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1097\/01.TP.0000117782.93598.6E","article-title":"Approaches to transplantation tolerance in humans.","volume":"77","author":"Strober","year":"2004","journal-title":"Transplantation"},{"key":"R91-5-20210203","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ni0508-447","article-title":"Autoimmunity and transplantation: a meeting at the crossroads in Berlin.","volume":"9","author":"Sawitzki","year":"2008","journal-title":"Nat Immunol"},{"key":"R94-5-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cll.2008.08.003","article-title":"Microarrays: monitoring for transplant tolerance and mechanistic insights.","volume":"28","author":"Zarkhin","year":"2008","journal-title":"Clin Lab Med"},{"key":"R95-5-20210203","first-page":"775","article-title":"Microarrays: a monitoring tool for transplant patients Transplant Int.","volume":"19","author":"Weintraub","year":"2006","journal-title":""},{"key":"R96-5-20210203","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1097\/01.tp.0000222912.69532.1e","article-title":"Tolerance assays: measuring the unknown.","volume":"81","author":"Newell","year":"2006","journal-title":"Transplantation"},{"key":"R97-5-20210203","first-page":"2652","article-title":"How can we measure immunologic tolerance in humans J Am Soc Nephrol.","volume":"17","author":"Najafian","year":"2006","journal-title":""},{"key":"R98-5-20210203","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/01.TP.0000117778.83216.29","article-title":"Ethics in the quest for transplant tolerance.","volume":"77","author":"Kirk","year":"2004","journal-title":"Transplantation"},{"key":"R99-5-20210203","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/TP.0b013e31819d415e","article-title":"Clinical tolerance 2008.","volume":"87","author":"Kirk","year":"2009","journal-title":"Transplantation"},{"key":"R100-5-20210203","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood.V96.12.3997","article-title":"Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis.","volume":"96","author":"Matthes-Martin","year":"2000","journal-title":"Blood"},{"key":"R101-5-20210203","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00277-005-1076-7","article-title":"Liver transplantation after stem cell transplantation with the same living donor in a monozygotic twin with acute myeloid leukemia.","volume":"84","author":"Mellgren","year":"2005","journal-title":"Ann Hematol"},{"key":"R102-5-20210203","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trim.2004.05.004","article-title":"Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.","volume":"13","author":"Donckier","year":"2004","journal-title":"Transplant Immunol"},{"key":"R103-5-20210203","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/lt.20872","article-title":"Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion.","volume":"12","author":"Donckier","year":"2006","journal-title":"Liver Transplantation"},{"key":"R104-5-20210203","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MOT.0b013e328317a476","article-title":"Regulatory T cells as therapeutic cells.","volume":"13","author":"Sagoo","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"R105-5-20210203","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2165\/00003495-200868150-00004","article-title":"Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.","volume":"68","author":"Golshayan","year":"2008","journal-title":"Drugs"},{"key":"R106-5-20210203","first-page":"389","article-title":"Regulatory T cells after organ transplantation: where does their action take place Hum Immunol.","volume":"69","author":"Dijke","year":"2008","journal-title":""}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SLA.0b013e3181f3efb0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:31Z","timestamp":1786041331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000658-201012000-00005"}},"subtitle":["Current Status and Future Challenges"],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0b013e3181f3efb0","relation":{},"ISSN":["0003-4932"],"issn-type":[{"value":"0003-4932","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}